Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a randomized pilot trial.

Cardiovasc Diabetol · 2024 · PMC11344929 · PMID 39182114

Europe PMC DOI

hedged sentence

0.0930

closest p · 1.9× alpha

0.0930

boldest claim

The sentences

did not reach statistical significanceP = 0.093so close (0.05 < p ≤ 0.1)

The differences in the variation of ABI values among groups did not reach statistical significance ( P = 0.093).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.